Journal
IMMUNITY
Volume 46, Issue 2, Pages 233-244Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2017.01.005
Keywords
-
Categories
Funding
- European Research Council [338954-DIDO]
- Ministero dell'Istruzione, Universita e Ricerca, Italy [FIRB RBAP11T3WB]
Ask authors/readers for more resources
Arginase 1 (Arg1) and indoleamine 2,3-dioxygenase 1 (IDO1) are immunoregulatory enzymes catalyzing the degradation of L-arginine and L-tryptophan, respectively, resulting in local amino acid deprivation. In addition, unlike Arg1, IDO1 is also endowed with non-enzymatic signaling activity in dendritic cells (DCs). Despite considerable knowledge of their individual biology, no integrated functions of Arg1 and IDO1 have been reported yet. We found that IDO1 phosphorylation and consequent activation of IDO1 signaling in DCs was strictly dependent on prior expression of Arg1 and Arg1-dependent production of polyamines. Polyamines, either produced by DCs or released by bystander Arg1(+) myeloid-derived suppressor cells, conditioned DCs toward an IDO1-dependent, immunosuppressive phenotype via activation of the Src kinase, which has IDO1-phosphorylating activity. Thus our data indicate that Arg1 and IDO1 are linked by an entwined pathway in immuno-metabolism and that their joint modulation could represent an important target for effective immunotherapy in several disease settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available